Gainers
- Zymeworks Inc. (NASDAQ:ZYME) rose 40.3% to $6.97 in pre-market trading. Zymeworks 13D filing confirmed earlier reporting of offer letter from Blue Falcons for $10.50 per share.
- Finch Therapeutics Group, Inc. (NASDAQ:FNCH) shares rose 40% to $2.94 in pre-market trading. The U.S. Food and Drug Administration (FDA) removed the clinical hold on Finch Therapeutics Group investigational new drug (IND) application for CP101 in the prevention of recurrent C. difficile infection (CDI).
- NewAge, Inc. (NASDAQ:NBEV) rose 32.4% to $0.53 in pre-market trading.
- JD.com, Inc. (NASDAQ:JD) rose 14.6% to $66.29 in pre-market trading. JD.com filed its annual report on Form 20-F for the fiscal year ended December 31, 2021.
- GDS Holdings Limited (NASDAQ:GDS) rose 14.4% to $33.90 in pre-market trading. GDS Holdings filed its annual report on Form 20-F for the fiscal year ended December 31, 2021.
- DiDi Global Inc. (NYSE:DIDI) rose 13.7% to $2.06 in pre-market trading.
- Pinduoduo Inc. (NASDAQ:PDD) rose 13.7% to $43.15 in pre-market trading.
- Bilibili Inc. (NASDAQ:BILI) rose 13.7% to $25.25 in pre-market trading.
- Full Truck Alliance Co. Ltd. (NASDAQ:YMM) rose 13.6% to $5.69 in pre-market trading.
- Digital World Acquisition Corp. (NASDAQ:DWAC) rose 13.1% to $54.34 in pre-market trading after gaining 8% on Thursday.
- iQIYI, Inc. (NASDAQ:IQ) shares rose 12.6% to $3.76 in pre-market trading.
- Alibaba Group Holding Limited (NYSE:BABA) rose 12.2% to $102.00 in pre-market trading. Analysts slashed the earnings estimates for the Chinese technology giants for a second straight month amid the nation’s persistent goal of its Covid-Zero strategy, Bloomberg reported. Analysts trimmed Alibaba Group estimates by 4.2%.
- KE Holdings Inc. (NASDAQ:BEKE) rose 11.7% to $14.88 in pre-market trading.
- Kingsoft Cloud Holdings Limited (NASDAQ:KC) rose 11.5% to $4.15 in pre-market trading after gaining over 6% on Thursday.
- Innate Pharma S.A. (NASDAQ:IPHA) rose 10% to $2.97 in pre-market trading after the company said it has dosed first patient in Monalizumab Phase 3 lung cancer clinical trial.
- Aurora Mobile Limited (NASDAQ:JG) rose 7.7% to $0.89 in pre-market trading.
